Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Background and Associated Industry Indicators
- 4. Global Market Demand Analysis 2018 to 2022 and Forecast, 2023 to 2033
- 5. Global Market - Pricing Analysis
- 6. Global Market Demand (in Value or Size in US$ Mn) Analysis 2018 to 2022 and Forecast, 2023 to 2033
- 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
- 7.1 Multiple Sclerosis
- 7.2 Alzheimer’s Disease
- 7.3 Parkinson Disease
- 7.4 Acute Migraine
- 7.5 Autism
- 7.6 Narcolepsy
- 7.7 Amyotrophic Lateral Sclerosis (ALS)
- 7.8 Attention Deficit Hyperactivity Disorder (ADHD)
- 7.9 Spinal Muscular Atrophy
- 7.10 Tourette Syndrome
- 7.11 Huntington’s Disease
- 7.12 Others
- 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
- 8.1 Neurotransmitter Agents
- 8.2 Neuroprotective Agents
- 8.3 Biologics
- 8.4 Others
- 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
- 9.1 Hospital Pharmacies
- 9.2 Online Pharmacies
- 9.3 Retail Pharmacies
- 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
- 10.1 North America
- 10.2 Europe
- 10.3 Asia Pacific
- 10.4 Latin America
- 10.5 Middle East & Africa
- 11. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 13. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 14. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 16. Key Countries Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 17. Market Structure Analysis
- 18. Competition Analysis
- 18.1 Allergan Plc
- 18.2 Bayer AG
- 18.3 F. Hoffmann-La Roche Ltd.
- 18.4 GlaxoSmithKline Plc
- 18.5 Johnson & Johnson
- 18.6 Merck KGaA
- 18.7 Novartis AG
- 18.8 Pfizer Inc.
- 18.9 Sanofi
- 18.10 Teva Pharmaceuticals Industries Ltd.
- 19. Assumptions and Acronyms Used
- 20. Research Methodology
List of Tables
Table 01: Global Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 02: Global Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 03: Global Market Value (US$ Mn) Forecast, by Drug Class, 2023 to 2033
Table 04: Global Market Value (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033
Table 05: Global are Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Region, 2023 to 2033
Table 06: North America Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033
Table 07: North America Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 08: North America Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 09: North America Market Value (US$ Mn) Forecast, by Drug Class, 2023 to 2033
Table 10: North America Market Value (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033
Table 11: Europe Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033
Table 12: Europe Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 13: Europe Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 14: Europe Market Value (US$ Mn) Forecast, by Drug Class, 2023 to 2033
Table 15: Europe Market Value (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033
Table 16: Asia Pacific Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033
Table 17: Asia Pacific Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 18: Asia Pacific Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 19: Asia Pacific Market Value (US$ Mn) Forecast, by Drug Class, 2023 to 2033
Table 20: Asia Pacific Market Value (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033
Table 21: Latin America Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033
Table 22: Latin America Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 23: Latin America Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 24: Latin America Market Value (US$ Mn) Forecast, by Drug Class, 2023 to 2033
Table 25: Latin America Market Value (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033
Table 26: Middle East & Africa Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033
Table 27: Middle East & Africa Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 28: Middle East & Africa Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033
Table 29: Middle East & Africa Market Value (US$ Mn) Forecast, by Drug Class, 2023 to 2033
Table 30: Middle East & Africa Market Value (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033
List of Figures
Figure 01: Global Market Value (US$ Mn) Forecast, 2023 to 2033
Figure 02: Global Market Value Share, by Indication, 2023
Figure 03: Global Market Value Share, by Drug Class, 2023
Figure 04: Global Market Value Share, by Distribution Channel, 2023
Figure 05: Global Market Value Share, by Region, 2023
Figure 06: Global Market Value Share Analysis, by Indication, 2023 and 2033
Figure 07: Global Market Attractiveness Analysis, by Indication, 2023 to 2033
Figure 08: Global Market Value (US$ Mn), by Multiple Sclerosis (MS), 2023 to 2033
Figure 09: Global Market Value (US$ Mn), by Alzheimer’s Disease, 2023 to 2033
Figure 10: Global Market Value (US$ Mn), by Parkinson's Disease, 2023 to 2033
Figure 11: Global Market Value (US$ Mn), by Acute Migraine, 2023 to 2033
Figure 12: Global Market Value (US$ Mn), by Autism, 2023 to 2033
Figure 13: Global Market Value (US$ Mn), by Narcolepsy, 2023 to 2033
Figure 14: Global Market Value (US$ Mn), by Amyotrophic Lateral Sclerosis (ALS), 2023 to 2033
Figure 15: Global Market Value (US$ Mn), by Attention Deficit Hyperactivity Disorder (ADHD), 2023 to 2033
Figure 16: Global Market Value (US$ Mn), by Spinal Muscular Atrophy, 2023 to 2033
Figure 17: Global Market Value (US$ Mn), by Tourette Syndrome, 2023 to 2033
Figure 18: Global Market Value (US$ Mn), by Huntington's disease, 2023 to 2033
Figure 19: Global Market Value (US$ Mn), by Others, 2023 to 2033
Figure 20: Global Market Value Share Analysis, by Drug Class, 2023 and 2033
Figure 21: Global Market Attractiveness Analysis, by Drug Class, 2023 to 2033
Figure 22: Global Market Value (US$ Mn), by Neuroprotective Agents, 2023 to 2033
Figure 23: Global Market Value (US$ Mn), by Neurotransmitter Agents, 2023 to 2033
Figure 24: Global Market Value (US$ Mn), by Biologics, 2023 to 2033
Figure 25: Global Market Value (US$ Mn), by Others, 2023 to 2033
Figure 26: Global Market Value Share Analysis, by Distribution Channel, 2023 and 2033
Figure 27: Global Market Attractiveness Analysis, by Distribution Channel, 2023 to 2033
Figure 28: Global Market Value (US$ Mn), by Hospital Pharmacies, 2023 to 2033
Figure 29: Global Market Value (US$ Mn), by Online Pharmacies, 2023 to 2033
Figure 30: Global Market Value (US$ Mn), by Retail Pharmacies, 2023 to 2033
Figure 31: Global Market Value Share Analysis, by Region, 2023 and 2033
Figure 32: Global Market Attractiveness Analysis, by Region, 2023 to 2033
Figure 33: North America Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023 to 2033
Figure 34: North America Market Attractiveness Analysis, by Country, 2023 and 2033
Figure 35: North America Market Value Share Analysis, by Country, 2023 to 2033
Figure 36: North America Market Value Share Analysis, by Indication, 2023 and 2033
Figure 37: North America Market Attractiveness Analysis, by Indication, 2023 to 2033
Figure 38: North America Market Value Share Analysis, by Drug Class, 2023 and 2033
Figure 39: North America Market Attractiveness Analysis, by Drug Class, 2023 to 2033
Figure 40: North America Market Value Share Analysis, by Distribution Channel, 2023 and 2033
Figure 41: North America Market Attractiveness Analysis, by Distribution Channel, 2023 to 2033
Figure 42: Europe Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023 to 2033
Figure 43: Europe Market Attractiveness Analysis, by Country/Sub-region, 2023 and 2033
Figure 44: Europe Market Value Share Analysis, by Country/Sub-region, 2023 to 2033
Figure 45: Europe Market Value Share Analysis, by Indication, 2023 and 2033
Figure 46: Europe Market Attractiveness Analysis, by Indication, 2023 to 2033
Figure 47: Europe Market Value Share Analysis, by Drug Class, 2023 and 2033
Figure 48: Europe Market Attractiveness Analysis, by Drug Class, 2023 to 2033
Figure 49: Europe Market Value Share Analysis, by Distribution Channel, 2023 and 2033
Figure 50: Europe Market Attractiveness Analysis, by Distribution Channel, 2023 to 2033
Figure 51: Asia Pacific Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023 to 2033
Figure 52: Asia Pacific Market Attractiveness Analysis, by Country/Sub-region, 2023 and 2033
Figure 53: Asia Pacific Market Value Share Analysis, by Country/Sub-region, 2023 to 2033
Figure 54: Asia Pacific Market Value Share Analysis, by Indication, 2023 and 2033
Figure 55: Asia Pacific Market Attractiveness Analysis, by Indication, 2023 to 2033
Figure 56: Asia Pacific Market Value Share Analysis, by Drug Class, 2023 and 2033
Figure 57: Asia Pacific Market Attractiveness Analysis, by Drug Class, 2023 to 2033
Figure 58: Asia Pacific Market Value Share Analysis, by Distribution Channel, 2023 and 2033
Figure 59: Asia Pacific Market Attractiveness Analysis, by Distribution Channel, 2023 to 2033
Figure 60: Latin America Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023 to 2033
Figure 61: Latin America Market Attractiveness Analysis, by Country/Sub-region, 2023 and 2033
Figure 62: Latin America Market Value Share Analysis, by Country/Sub-region, 2023 to 2033
Figure 63: Latin America Market Value Share Analysis, by Indication, 2023 and 2033
Figure 64: Latin America Market Attractiveness Analysis, by Indication, 2023 to 2033
Figure 65: Latin America Market Value Share Analysis, by Drug Class, 2023 and 2033
Figure 66: Latin America Market Attractiveness Analysis, by Drug Class, 2023 to 2033
Figure 67: Latin America Market Value Share Analysis, by Distribution Channel, 2023 and 2033
Figure 68: Latin America Market Attractiveness Analysis, by Distribution Channel, 2023 to 2033
Figure 69: Middle East & Africa Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023 to 2033
Figure 70: Middle East & Africa Market Attractiveness Analysis, by Country/Sub-region, 2023 and 2033
Figure 71: Middle East & Africa Market Value Share Analysis, by Country/Sub-region, 2023 to 2033
Figure 72: Middle East & Africa Market Value Share Analysis, by Indication, 2023 and 2033
Figure 73: Middle East & Africa Market Attractiveness Analysis, by Indication, 2023 to 2033
Figure 74: Middle East & Africa Market Value Share Analysis, by Drug Class, 2023 and 2033
Figure 75: Middle East & Africa Market Attractiveness Analysis, by Drug Class, 2023 to 2033
Figure 76: Middle East & Africa Market Value Share Analysis, by Distribution Channel, 2023 and 2033
Figure 77: Middle East & Africa Market Attractiveness Analysis, by Distribution Channel, 2023 to 2033
Figure 78: Global Market Share Analysis, by Company, 2023
